Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040025 · ClinicalTrials.gov registry record
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02040025 is a clinical trial that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT02040025 was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02040025
The ClinicalTrials.gov registry entry for NCT02040025 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02040025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02040025 about?
NCT02040025 is a clinical study titled "Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus". The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.
What is the current status of trial NCT02040025?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2014-04. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02040025?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.